Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer
- PMID: 11325856
Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer
Abstract
Amplification of 3q25-q26 was one of the most frequent chromosomal alterations in human ovarian carcinoma. A chromosome microdissection-hybrid selection method was applied to isolate transcribed sequences from a primary ovarian cancer containing high-copy-number amplification of 3q26 using 3q26 band-specific DNAs generated by chromosome microdissection. Using this method, we have isolated a novel candidate oncogene eIF-5A2 (eukaryotic initiation factor 5A2). eIF-5A2 shares 82% identity of amino acid sequence with eIF-5A including the minimum domain needed for eIF-5A maturation by hypusine modification at lysine-50 residue. Amplification and overexpression of eIF-5A2 was frequently detected in primary ovarian cancers and ovarian cancer cell lines. The proliferation-related function of eIF-5A supports that eIF-5A2 is a candidate oncogene related to the development of ovarian cancer.
Similar articles
-
Oncogenic role of eIF-5A2 in the development of ovarian cancer.Cancer Res. 2004 Jun 15;64(12):4197-200. doi: 10.1158/0008-5472.CAN-03-3747. Cancer Res. 2004. PMID: 15205331
-
Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.Gynecol Oncol. 2009 Feb;112(2):314-8. doi: 10.1016/j.ygyno.2008.10.024. Epub 2008 Dec 2. Gynecol Oncol. 2009. PMID: 19054548
-
Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma.Hum Pathol. 2008 Jan;39(1):80-6. doi: 10.1016/j.humpath.2007.05.011. Epub 2007 Oct 18. Hum Pathol. 2008. PMID: 17949776
-
The role of protein elongation factor eEF1A2 in ovarian cancer.Reprod Biol Endocrinol. 2003 Oct 7;1:69. doi: 10.1186/1477-7827-1-69. Reprod Biol Endocrinol. 2003. PMID: 14588074 Free PMC article. Review.
-
Cytogenetics and molecular genetics of ovarian cancer.Am J Med Genet. 2002 Oct 30;115(3):157-63. doi: 10.1002/ajmg.10695. Am J Med Genet. 2002. PMID: 12407696 Review.
Cited by
-
Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.Am J Pathol. 2001 Dec;159(6):2089-94. doi: 10.1016/S0002-9440(10)63060-X. Am J Pathol. 2001. PMID: 11733359 Free PMC article.
-
Eukaryotic initiation factor 5A2 and human digestive system neoplasms.World J Gastrointest Oncol. 2019 Jun 15;11(6):449-458. doi: 10.4251/wjgo.v11.i6.449. World J Gastrointest Oncol. 2019. PMID: 31236196 Free PMC article. Review.
-
High Expression of LAMP3 Is a Novel Biomarker of Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.Int J Mol Sci. 2015 Jul 31;16(8):17655-67. doi: 10.3390/ijms160817655. Int J Mol Sci. 2015. PMID: 26263981 Free PMC article.
-
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.Cancer Res. 2014 Nov 15;74(22):6671-81. doi: 10.1158/0008-5472.CAN-14-1031. Epub 2014 Sep 26. Cancer Res. 2014. PMID: 25261239 Free PMC article.
-
Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression.Oncotarget. 2014 Aug 30;5(16):6716-33. doi: 10.18632/oncotarget.2236. Oncotarget. 2014. PMID: 25071013 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases